Supreme Court of Canada reserves decision in AstraZeneca v Apotex

11-11-2016

Supreme Court of Canada reserves decision in AstraZeneca v Apotex

The Supreme Court of Canada heard oral arguments in AstraZeneca v Apotex and reserved its decision about patent utility and the ‘promise doctrine’, in a case centring on pharmaceutical company AstraZeneca’s heartburn relief drug Nexium (esomeprazole magnesium).


AstraZeneca v Apotex, Astrazeneca, Apotex, patent, utility, gastric acid, Nexium, Supreme Court of Canada, promise doctrine,

LSIPR